Literature DB >> 17333494

Antihypertensive drug utilization at health centres in a district of Istanbul.

Ahmet Akici1, Sibel Kalaça, Umit Uğurlu, Hale Z Toklu, Sule Oktay.   

Abstract

OBJECTIVE: Since irrational use of antihypertensives has considerable clinical and economical consequences, this study was conducted to evaluate antihypertensive drug utilization in hypertension at seven State Health Centres in Istanbul.
METHOD: A total of 297 hypertensive patients who accepted to participate in the study were evaluated by a face-to-face questionnaire and a copy of their prescriptions were collected for prescription analysis.
RESULTS: Angiotensin-converting enzyme (ACE) inhibitors (31.7%), calcium channel blockers (28.8%), diuretics (16.2%), beta blockers (7.5%) and others (15.8%) have been prescribed. There were no statistically significant relation between prescribed antihypertensive drug groups and gender, age, and NSAIDs co-prescribing. The most frequent comorbidity in hypertensive patients was diabetes mellitus (10.4%) and calcium channel blockers (35.5%) have been prescribed to them as a first antihypertensive medication. Average cost per prescription was $42.7 +/- 38.1. According to the patients' self-reporting, the majority of them (85%) were prescribed without a physical examination. The physicians failed to write the prescriptions appropriately; only 5% of the scripts contained all information about the drug(s) and use instructions in full format.
CONCLUSION: The present study indicates that GPs working at primary healthcare centres were rational in terms of antihypertensive drug choice. However, they poorly applied rational pharmacotherapy principles such as (a) writing a "good" prescription which is easily readable by the pharmacist and the patient and that contains full essential information; (b) a medical examination of the patient to assess her/his current clinical condition; and (c) taking care of not prescribing drugs with potential interaction like antihypertensives and NSAIDs together.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333494     DOI: 10.1007/s11096-007-9103-5

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  28 in total

1.  Simple, shared guidelines raise the quality of antihypertensive treatment in routine care.

Authors:  Fausto Avanzini; Alessandra Corsetti; Teresa Maglione; Claudio Alli; Fabio Colombo; Valter Torri; Irene Floriani; Gianni Tognoni
Journal:  Am Heart J       Date:  2002-10       Impact factor: 4.749

Review 2.  A family physician questions the conclusions from ALLHAT.

Authors:  John B Standridge
Journal:  Am J Hypertens       Date:  2004-04       Impact factor: 2.689

3.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

4.  Academic detailing to improve antihypertensive prescribing patterns.

Authors:  David Siegel; Julio Lopez; Joy Meier; Mary K Goldstein; Samuel Lee; Bradley J Brazill; Mazen S Matalka
Journal:  Am J Hypertens       Date:  2003-06       Impact factor: 2.689

5.  Why are physicians not prescribing diuretics more frequently in the management of hypertension?

Authors:  M Moser
Journal:  JAMA       Date:  1998-06-10       Impact factor: 56.272

6.  Prescribing habits of general practitioners in the treatment of childhood respiratory-tract infections.

Authors:  Ahmet Akici; Sibel Kalaça; M Umit Uğurlu; Sule Oktay
Journal:  Eur J Clin Pharmacol       Date:  2004-03-31       Impact factor: 2.953

7.  Impact of a short postgraduate course in rational pharmacotherapy for general practitioners.

Authors:  Ahmet Akici; Sibel Kalaça; M Umit Ugurlu; Atila Karaalp; Sanda Cali; Sule Oktay
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

8.  Treatment of high blood pressure in Germany.

Authors:  H D Faulhaber; F C Luft
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

9.  Actions implemented to improve hypertension control in Spain.

Authors:  H Pardell; R Tresserras; P Armario; R Hernandez
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

10.  Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

Authors:  F H Messerli; E Grossman; U Goldbourt
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

View more
  4 in total

1.  Aspects of physicians' attitudes towards the rational use of drugs at a training and research hospital: a survey study.

Authors:  Nesrin Filiz Basaran; Ahmet Akici
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

2.  A pharmacovigilance study of antihypertensive medicines at a South delhi hospital.

Authors:  A Hussain; M Aqil; M S Alam; M R Khan; P Kapur; K K Pillai
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

3.  Antihypertensive Prescription Pattern and Compliance to JNC 7 and JNC 8 at Tertiary Care Government Hospital, Hyderabad, India: A Cross-sectional Retrospective Study.

Authors:  Varsha Varakantham; Ashok Kumar Kurakula Sailoo; Dinesh Kumar Bharatraj
Journal:  Hosp Pharm       Date:  2017-11-01

4.  A qualitative exploration of hypertensive patients' perception towards quality use of medication and hypertension management at the community level.

Authors:  Ching S Tan; Mohamed A Hassali; Chin F Neoh; Fahad Saleem
Journal:  Pharm Pract (Granada)       Date:  2017-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.